WuXi AppTec Co., Ltd. (WUXIF) एक सार्वजनिक रूप से कारोबार करने वाली कंपनी है में स्वास्थ्य सेवा क्षेत्र, संचालन करती है Medical - Diagnostics & Research उद्योग. कंपनी का मुख्यालय है Shanghai, China. वर्तमान CEO हैं Ge Li.
WUXIF के पास है IPO तिथि 2020-03-17, 39,414 पूर्णकालिक कर्मचारी, पर सूचीबद्ध Other OTC, बाजार पूंजीकरण $41.41B.
WuXi AppTec Co., Ltd. is a leading contract research, development, and manufacturing organization headquartered in Shanghai, China. The company provides comprehensive services across the drug development lifecycle, including discovery, preclinical testing, clinical trials, and commercial manufacturing for small molecule drugs, biologics, and cell and gene therapies. Operating through six business segments—WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and others—the company serves pharmaceutical and biotech customers globally across China, Asia, the United States, Europe, and international markets. Founded in 2000, WuXi AppTec has established itself as an integrated solution provider that supports clients from early-stage drug discovery through commercialization across multiple therapeutic modalities.
